Lexaria Bioscience (LEXX) Earnings
Lexaria Bioscience's next earnings report is expected on Wednesday, November 25, 2026, with EPS expected around -0.90.
Summary
In the quarter ended May 2026, Lexaria Bioscience had revenue of $0, and diluted EPS of -0.08.
On July 13, 2026 it reported EPS of -0.08 against an estimate of -0.06 (missed).
Report dates
| Report | Date | Time | EPS estimate | EPS reported | Result |
|---|---|---|---|---|---|
| Next | Wed Nov 25, 2026 | — | -0.90 | — | — |
| Last | Mon Jul 13, 2026 | — | -0.06 | -0.08 | Missed |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Also reporting the week of November 23
| Company | Date | Time |
|---|---|---|
| Dell Technologies Inc DELL | Tue Nov 24 | After close |
| Deere & Company DE | Wed Nov 25 | Before open |
| Analog Devices Inc ADI | Tue Nov 24 | Before open |
| Medtronic PLC MDT | Tue Nov 24 | Before open |
| Hewlett Packard Enterprise Co HPE | Mon Nov 23 | After close |
| Autodesk Inc ADSK | Tue Nov 24 | After close |
| Agilent Technologies Inc A | Mon Nov 23 | After close |
| Workday Inc WDAY | Tue Nov 24 | After close |
Quarterly results
The last 12 quarters from Lexaria Bioscience's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| May 31, 2026 | $0 | — | -0.08 | — | — | 2026-07-13 |
| Feb 28, 2026 | $20,000 | -88.5% | -0.06 | — | -7259.5% | 2026-04-13 |
| Nov 30, 2025 | $0 | — | -0.07 | — | — | 2026-01-13 |
| Aug 31, 2025 | $174,000 | +107.1% | — | — | -1545.2% | 2025-11-28 |
| May 31, 2025 | $174,000 | +107.1% | -0.21 | — | -2155.4% | 2025-07-14 |
| Feb 28, 2025 | $174,000 | +20.0% | -0.15 | — | -1581.0% | 2025-04-14 |
| Nov 30, 2024 | $183,923 | +21.6% | -0.16 | — | -1463.0% | 2025-01-10 |
| Aug 31, 2024 | $84,000 | +173.3% | — | — | -2622.7% | 2024-11-26 |
| May 31, 2024 | $84,000 | +8.1% | -0.13 | — | -2074.9% | 2024-07-12 |
| Feb 29, 2024 | $145,000 | +624.1% | -0.06 | — | -460.7% | 2024-04-09 |
| Nov 30, 2023 | $151,278 | +54.8% | -0.13 | — | -753.0% | 2024-01-12 |
| Aug 31, 2023 | $30,741 | -72.3% | — | — | -3624.2% | 2023-11-20 |
Questions about Lexaria Bioscience
When does Lexaria Bioscience report earnings?
Lexaria Bioscience's next earnings report is expected on November 25, 2026.
Did Lexaria Bioscience beat earnings estimates?
In its report on July 13, 2026, Lexaria Bioscience missed the EPS estimate: -0.08 reported against -0.06 expected.
How did Lexaria Bioscience do last quarter?
In the quarter ended May 2026, Lexaria Bioscience had revenue of $0, and diluted EPS of -0.08.
From Lexaria Bioscience's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.